Skip to content
MarketScale
‹ Back to IndustriesHealthcare

A Category Deep Dive on Dialysis

Dialysis is a necessary procedure that allows nearly 500,000 patientsin the United States with kidney failure the opportunity to live normal, productive lives. The treatment removes waste, salt, and extra water when the native kidneys are no longer able. Though there are several types of dialysis, the most common is Hemodialysis, in which blood is removed from the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Dialysis is a necessary procedure that allows nearly 500,000 patientsin the United States with kidney failure the opportunity to live normal, productive lives. The treatment removes waste, salt, and extra water when the native kidneys are no longer able. Though there are several types of dialysis, the most common is Hemodialysis, in which blood is removed from the body, run through a dialyzer, cleaned, and replaced into the body. Dialysis takes three hours to complete and is offered by health systems as inpatient and outpatient treatments.

The federal government pays 80% of all dialysis costs for most patients via Medicare. In fact, the dialysis industry experienced large significant in 1972 when procedures became covered through this program. The industry is run on a for-profit basis, with the market being dominated by two large publicly traded companies known as DaVita and Fresenius. Smaller communities and rural healthcare organizations are more likely to turn to the many local and regional dialysis service providers. Additionally, hospitals or treatment centers must assess the option of operating their own dialysis center for maximum convenience to their patients.

Technology is available to help determine every cost within every purchased services expense category of a health system, revealing massive savings potential in important areas, including dialysis. Here are several factors that healthcare providers should know about dialysis when considering opportunities for savings.

  • The Need for Dialysis is Going Up: The number of patients requiring End Stage Renal Dialysis treatment is increasing each year, with mortality rates depending on the treatment. ESRD, or renal failure, is the fastest-growing cause of hospitalizations, and the fifth leading reason for readmissions.
  • Dialysis Is a Competitive Business. With multiple options usually available for health systems, it’s essential to ensure your organization has evaluated them all recently. Joint ventures between hospitals or health systems and dialysis providers are common. A patient’s choice in healthcare provider and dialysis company are critical factors in driving usage of centers.
  • Savings Opportunities Exist in the Cost of Smaller Purchased Services: Ongoing dialysis treatments can be categorized into purchased services, which is any service contracted and performed by a third party as opposed to the in-house staff at the hospital. Purchased services can account for up to 45% of an average U.S. hospital’s non-labor expenses. However, most health systems continuously tackle savings within the larger categories only, including food, EVS, and blood, ignoring the smaller purchased services categories.
  • Categorize the Entire Spend in a System: Without categorizing their entire purchased services spend and prioritizing opportunities, health systems are missing out on addressing smaller categories—including dialysis—that still have large savings opportunities. Why? Without technology, many systems are not able to categorize their entire organization’s spend and prioritize these kinds of opportunities.

Effective Category Monitoring Helps Health Systems Thrive

By prioritizing opportunities and categorizing purchased service costs, health systems will no longer fail to acknowledge dialysis and other smaller categories. Hospitals and healthcare systems using purchased services expense management technology can identify areas of financial improvement in smaller categories like dialysis by utilizing software that not only identifies but breaks down purchased services and reveals a deeper understanding of the overall costs.

Many Americans require dialysis treatment; however, it is an often-ignored category within purchases services that has potential for great savings. At Valify, we offer a breakthrough technology that uses innovative tools to reveal savings opportunities for each expense, saving hospitals 20-30% per purchased service category, on average.

To discover how our technology platform operates, request a live demo at getvalify.com/demo-valify.

Read more at getvalify.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512